IntelliCell manufactures SVF cells from non-living donated adipose tissue
The cells have been grown in culture and have the correct CD antibody markers for mesenchymal stem cells and other cells that are consistent with SVF cells. SVF
Novartis has signed an agreement to purchase Myricx Bio, a UK-based biotechnology company, in a transaction valued at up to $1.5bn.